NEW YORK (GenomeWeb) – Signature Science said yesterday that it has been awarded a contract from the US Centers for Disease Control and Prevention to evaluate and develop molecular tools to detect and follow the spread of specific bacteria and microbial communities in healthcare settings.

Brian Schimmoller, vice president at Austin, Texas-based Signature Science, noted in an email that the 12-month contract has a value of approximately $560,000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

CNBC reports that half of academic researchers leave after about five years.

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.